Charles River Laboratories International (CRL) Other Non-Current Liabilities (2016 - 2025)
Charles River Laboratories International has reported Other Non-Current Liabilities over the past 17 years, most recently at $138.3 million for Q4 2025.
- Quarterly results put Other Non-Current Liabilities at $138.3 million for Q4 2025, down 29.15% from a year ago — trailing twelve months through Dec 2025 was $138.3 million (down 29.15% YoY), and the annual figure for FY2025 was $138.3 million, down 29.15%.
- Other Non-Current Liabilities for Q4 2025 was $138.3 million at Charles River Laboratories International, down from $189.5 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for CRL hit a ceiling of $242.9 million in Q4 2021 and a floor of $138.3 million in Q4 2025.
- Median Other Non-Current Liabilities over the past 5 years was $195.8 million (2024), compared with a mean of $201.8 million.
- Biggest five-year swings in Other Non-Current Liabilities: soared 37.19% in 2024 and later fell 29.15% in 2025.
- Charles River Laboratories International's Other Non-Current Liabilities stood at $242.9 million in 2021, then fell by 28.02% to $174.8 million in 2022, then increased by 27.67% to $223.2 million in 2023, then fell by 12.54% to $195.2 million in 2024, then dropped by 29.15% to $138.3 million in 2025.
- The last three reported values for Other Non-Current Liabilities were $138.3 million (Q4 2025), $189.5 million (Q3 2025), and $185.2 million (Q2 2025) per Business Quant data.